Relay Therapeutics CFO Sells $3.18 Million in Shares Amidst 500% Stock Surge
On June 22, 2026, Relay Therapeutics' Chief Financial Officer Thomas Catinazzo sold approximately $3.18 million worth of shares following an option exercise. The stock has surged over 500% in the past year despite ongoing financial losses.
